The capability of the current European strain of bluetongue virus serotype 8 (BTV-8) to cross the ruminant placenta has been established in experimental and field studies in both sheep and cattle. Sero-prevalence rates in goats in north-western Europe were high during the recent outbreak of BTV-8, however the capability of the virus to infect goats through the transplacental route has not been established. In the present study, four Saanen goats pregnant at 62 days of gestation were inoculated with the European strain of BTV-8, in order to investigate the capability of the virus to cross the caprine placenta. Infection of adult goats resulted in mild clinical signs, however gross lesions observed post mortem were more severe. 
Introduction
Bluetongue (BT) is a globally important viral haemorrhagic disease of domestic and wild ruminants (and in particular of sheep) that is caused by the arthropod transmitted bluetongue virus (BTV) (Orbivirus genus, family Reoviridae) (Borden et al., 1971; Mertens et al., 2005) .
Twenty six serotypes of the virus have been identified (Howell, 1960; Howell et al., 1970; Maan et al., 2007; Hofmann et al., 2008; Maan et al., 2011) based either on serotype-specific neutralisation of the viral outer capsid protein VP2 (Huismans and Erasmus, 1981; Huismans et al., 1987; Mertens et al., 1989) or analysis of VP2 amino acid sequence data (Hoffman et al., 2008; Maan et al., 2007; Maan et al., 2011) . Bluetongue virus is transmitted primarily through the bites of haematophagous midges (Culicoides spp. -Diptera: Ceratopogonidae), the biological vectors of the virus (Du Toit, 1944) . The distribution of the virus is closely linked to the distribution of vector competent midge species and suitable climatic conditions that support the seasonal circulation of the virus. The virus therefore occurs mainly in tropical and subtropical regions of the world between the latitudes of 40-50°N and 35°S (Tabachnick, 2004) .
The global distribution of BTV has changed dramatically over the last two decades. This change in distribution has been particularly prominent in Europe, where several strains and serotypes have since 1998 caused outbreaks far north of the virus' traditional range in Northern Africa and the Mediterranean basin (Purse et al., 2005) . The most economically damaging outbreak of BT recorded in Europe started in 2006, when a strain of bluetongue virus serotypes 8 (BTV-8) was introduced through an unknown route into north-western Europe. The virus surprisingly managed to persist during the 2006-2007 winter period and re-emerged in May-June of 2007. During that year the virus spread to several additional European countries and affected over 55 000 holdings, resulting in economic losses totalling hundreds of millions of Euros (Maan et al., 2008; Velthuis et al., 2010) .
Several characteristics of the 2006-2008 outbreak of BTV-8 in north-western Europe made
it unusual when compared to BT outbreaks which have been caused by other strains and serotypes in other regions of the world. The virus was spread by Palearctic midge species (Meiswinkel et al., 2008) and appeared to be highly virulent, causing clinical disease not only in sheep, but also in cattle and goats (Thiry et al., 2006; Dercksen et al., 2007; Dal Pozzo et al., 2009) . It was also observed that infection of pregnant sheep and cattle resulted in a high incidence of reproductive failures including abortions, still births and malformations in offspring, suggesting that the virus had acquired the capability to cross the ruminant placenta (Wouda et al., 2008; Vercauteren et al., 2008; Desmecht et al., 2008) . Prior to the European outbreak of BTV-8, transplacental infection had generally only been associated with the vaccination of pregnant sheep and cattle with egg and cell culture adapted modified-live virus (MLV) vaccines of South African and American origin (Kirkland and Hawkes, 2004) , whereas wild-type strains were generally thought to be incapable of doing so. Therefore it was initially speculated that the BTV-8 outbreak was caused either by an MLV strain or a wild-type virus that had reassorted its genome segments with a MLV strain (Maan et al., 2008) .
Transplacental infection with the current European strain of BTV-8 has been investigated extensively in both sheep and cattle in experimental Backx et al., 2009; van der Sluijs et al., 2011) and field studies (De Clercq et al., 2008; Darpel et al., 2009a; SantmanBerends et al., 2010; Saegerman et al., 2010) in north-western Europe. Field surveys have indicated that the virus was extremely efficient at crossing the placenta. For example, transmission rates of 33-41% were recorded amongst calves born to previously infected dams in the field in the Netherland, Belgium and the United Kingdom (2007 Kingdom ( -2008 (Darpel et al., 2009; De Clercq et al., 2008; Desmecht et al., 2008) . The high frequency with which the BTV-8 strain was able to cross the placenta may have been a contributing factor that allowed the virus to persist during the adult vector free/low European winters. Several studies conducted in northwestern Europe have demonstrated the birth of seemingly healthy PCR positive and/or viraemic lambs or calves, some of which tested positive for viral RNA for several months (De Clercq et al., 2008; Menzies et al., 2008; Santman-Berends et al., 2010; Saegerman et al., 2010) . These animals may have served as a source of virus for newly emerged adult midges in subsequent vector seasons.
In August 2007 BT was reported for the first time in goats in the Netherlands. Despite the apparent susceptibility of goats to infection with BTV-8 only twenty five holdings throughout the Netherlands had reported outbreaks of the disease at the end of 2007 (Dercksen et al., 2007) .
The manifestation of clinical signs amongst BTV-8 infected goats in north-western Europe thus appears to have been a relatively rare occurrence. This was confirmed by a sero-prevalence study in the Netherlands (2007) that indicated that goats were infected at a high prevalence (estimated at 47%) (Elbers et al., 2008) . A similarly high sero-prevalence (estimated at 25%) was recorded amongst goats in Germany (Conraths et al., 2009) .
Although transplacental infection of sheep and cattle with the European strain of BTV-8 has been demonstrated, no information is currently available on the ability of BTV-8 to infect goats through this route. The ability of BTV-8 to overwinter by infecting goats via the transplacental route may however be significant, especially when considering the high sero-prevalence found amongst goats in Europe during the 2007-2008 outbreak. The present study describes an experiment designed to investigate whether BTV-8 is able to cross the caprine placenta.
Materials and method

Virus
Bluetongue virus serotype 8 that was isolated from a clinically affected bovine in the Netherlands in 2007 was used for infection (kindly provided by Dr. A. C. Potgieter, Deltamune, Pretoria, South Africa). The virus was originally isolated (E1/BHK2) at the International Institute for Animal Health, (Pirbright, UK) and is stored with the sample designation NET2007/01. A virus stock for inoculation was prepared by passing the virus twice in African green monkey kidney (Vero) cells (E1/BHK2/V2). Virus containing cell culture supernatant was subsequently titrated in Vero cells by using the endpoint dilution method previously described by Reed and Muench (1938) and diluted in cell culture medium to a final titre of 4.75 log 10 TCID 50 /ml.
African monkey green monkey kidney cells were grown in 75 cm 2 flasks containing 30 ml Dulbecco's Minimal Essential Medium (DMEM) supplemented with 5% foetal calf serum (v/v), 10% tryptose phosphate broth (v/v) and 1 mg/ml gentamycin and incubated at 37°C in an atmosphere containing 5% CO 2 until 90% confluent.
Animals
Non-parous pure-bred Saanen goats between 1 and 2 years of age were used in the trial. The animals were purchased from the Experimental Farm of the University of Pretoria ( Committee (AUCC project number V059-10).
Experimental design
At Day 62 of gestation (day 0 of the study) each pregnant goat was injected with 1 ml of BTV-8 inoculum in the jugular vein and 1 ml subcutaneously on the right side of the neck (total inoculum = 2 ml). Control animals were inoculated in a similar fashion with BTV negative cell culture medium. From day 1 following challenge, the goats were observed twice daily for clinical signs. In order to investigate infection of the foetuses, the BTV-8 inoculated goats were sequentially euthanised through the intravenous injection of sodium pentobarbitone (200mg/kg) at roughly two week intervals post infection [13 (animal 1), 25 (animal 2) and 43 (animals 3 and 4) dpi] and the foetuses and adults examined post mortem. The control animals (animals 5 and 6)
were euthanised at the end of the trial (46 dpi).
Sample collection
Blood samples (EDTA, heparin and serum) were collected from all goats prior to inoculation (day -14 and 0), daily for 21 dpi and weekly thereafter until the experimental endpoints. Skin samples were also taken from each animal on a weekly basis during the first 21 dpi and on the day of euthanasia. At necropsy tissues (skin, brain, submandibular lymph node, tonsils, lung, spleen, kidney, liver, heart, tongue, mammary tissue, uterus, cotyledon, foetal membranes and umbilical cord) and blood samples (EDTA, heparin and serum) were collected from adult goats and foetuses. Each animal was examined separately and the surfaces and instrumentation cleaned between euthanisation. Special care was also taken to avoid contamination of the foetuses with maternal blood.
Competive enzyme linked immunosorbent assay (cELISA)
Group-specific antibodies to BTV were measured in the goats at different intervals as previously described and in serum from foetuses at necropsy. The presence of group-specific antibodies was assessed using a cELISA (Veterinary Medical Research and Diagnostics, VRMD) according to the manufacturer's instructions. Percentage negativity values were calculated by using the following formula: [1 -(OD sample/ OD negative reference)] x 100 and a cut-off value of >50% used to distinguish between positive and negative sera.
Serum neutralization tests
Each serum sample that tested positive in the cELISA was tested in duplicate for the presence and titre of neutralizing antibodies to BTV-8 using a serum virus neutralization test (SNT) (OIE, 2004) .
RNA extraction
For real-time reverse transcriptase-polymerase chain reaction (real-time RT-PCR) and conventional RT-PCR (for sequencing), two different RNA extraction protocols were followed.
For real-time RT-PCR total RNA was extracted from 100 µl EDTA stabilized blood or 100 mg of tissue (preserved in RNAlater™, Ambion) by using Trizol (Invitrogen) according to the manufacturer's instructions and resuspended in 50 µl AVE buffer (QIAGEN). For conventional RT-PCR, selected blood and tissue samples were extracted several times by using Trizol. Viral double stranded RNA (dsRNA) was thereafter precipitated from total RNA (Potgieter et al., 2009 ) and concentrated by passing the dsRNA from several extraction replicates through one QIAquick™ PCR purification column (QIAGEN) prior to washing and elution.
Real-time RT-PCR targeting segment 5 (NS1)
Real-time RT-PCR was conducted on extracted total RNA from blood and tissue samples by using a two step procedure (Toussaint et al., 2007) . Briefly: Total RNA was denatured with 10% DMSO (v/v) at 95°C for three minutes prior to snap cooling on ice. Reverse transcription was thereafter performed on 2 µl RNA by using the High Capacity RNA to cDNA master mix (Applied Biosystems) and 1.25 µM random hexamers (25°C for 5 min, 42°C for 30 min and 95°C for 5 min). Real-time PCR was performed using the TaqMan ® Universal Master Mix II (Applied Biosystems) with 10 pmol of each of the primers BTV S5 F1-19 and BTV S5 R76-57, 2.5 pmol TaqMan probe (BTV S5 P 49-27) and 5 µl cDNA (20 ul in total). Cycling conditions were as follows; 1 cycle at 95°C for 10 min and 50 cycles at 95°C for 15 s followed by 58°C for 1 min. Mammalian beta-actin mRNA was amplified as an internal control by using the same conditions as described above. Samples were considered BTV positive if they demonstrated a cycle threshold (Ct) value <45.
Conventional RT-PCR and sequencing
Conventional PCR was conducted on enriched viral dsRNA Reactions that yielded the correct sized product (approx. 560 base pairs) were purified with a QIAquick® PCR purification kit (QIAGEN). Purified products (10 ng) were sequenced using the V 3.1 BigDye Terminator system (Applied Biosystems) and 2.5 pmol of either the reverse or forward primer. Unincorporated labelled ddNTPs were removed by ethanol-sodium acetate precipitation and the reactions resolved on an ABI 3100 DNA sequencer. Sequences were assembled and trimmed with the Staden package V4.1 (Bonfield et al., 1995) and were subjected to a nucleotide-nucleotide sequence BLAST on the National Centre for Biotechnology website (National Institute for Health, USA) in order to determine the sequence identities. A 499 base pair region of the VP2 encoding gene corresponding to nucleotide position 2163-2661 of BTV-8 was analyzed (results not shown).
Immunohistochemistry
Immuno-staining was performed on tissue samples preserved in 10% formalin buffered saline (Sanchez-Cordon et al., 2010) . In-house polyclonal antibodies directed towards the viral core protein (VP7) were used at a 1:200 dilution as primary antibodies for antigen detection. The immunoperoxidase test showed a strong positive reaction in positive control slides prepared from a clinical bluetongue field case (ovine, South Africa). Only a low level background staining was observed in negative control slides.
Virus isolation
Virus isolation was attempted from selected blood samples from both adults and foetuses (previously frozen at -80°C) that demonstrated the lowest Ct values in the real-time RT-PCR by using Culicoides sonorensis (KC) cells (Wechsler et al., 1989) . This was done in an attempt to demonstrate the presence and duration of infectious viraemia. Blood cell pellets (obtained from 1ml blood) were washed three times with 1 ml Dulbecco's PBS and resuspended in 1 ml supplemented Schneider's Drosophila Medium (Schneider, 1964) . Homogenization was performed in 2 ml tissue homogenization tubes (Roche) at 1000 Hz for 30 s using a tissue lyser (Precellys) prior to centrifugation at 10 000 x g for 10 min. Clarified supernatants (0.5 ml) were inoculated into 90% confluent KC cells (that previously tested negative for BTV contamination by using the Toussaint et al., 2007 real-time PCR assay) and incubated at 28°C for 7 days. Virus replication was confirmed by real-time RT-PCR (as previously described) on the cell culture supernatant. Total RNA was extracted from 200 µl clarified innoculum/supernatant with the Mini Viral RNA extraction kit (QIAGEN). The amount of input RNA for the NS1 real-time RT-PCR was standardized following quantification of total RNA by using a UV spectrophotometer.
Samples were considered to contain infective viruses if Ct values in the insect cell culture supernatant decreased relative to that of the original inoculums.
Results
Clinical signs
All BTV inoculated goats demonstrated a biphasic rise in body temperature (results not shown). The first rise occurred between 1-3 dpi and a second rise between 6-10 dpi. The temperatures peaked at 8 dpi and dropped back to baseline levels at 11 dpi. Only goat number 2 demonstrated temperatures above 40°C. Goat number 2 also showed moderate enlargement of the lymph nodes and slight hyperaemia/haemorrhage of the conjunctivae between 8-13 dpi. Multiple petechial haemorrhages were also seen in the tonsilar sinuses. The goat was carrying one foetus (3a). The foetus appeared normal externally but demonstrated a congested liver with focal areas of haemorrhaging. Localized areas of ecchymotic haemorrhages (2 mm in diameter)
were also recorded on the epicardium of the heart along the coronary groove. Goat number 4 demonstrated prominent congestion and petechial haemorrhages in the cortex and medulla of the submandibular lymph nodes (Fig. 1B) as well as focal areas of endocardial petechiation (10 mm in diameter) in both ventricles of the heart (Fig. 1C) . The animal carried three foetuses (4a-c) that appeared externally normal. Internally foetus 4a demonstrated petechiation of the caudal and cranial lobes of the lung (Fig. 1D) , a congested haemorrhagic liver (Fig. 1E) , a distinct circular haemorrhagic patch (3 mm in diameter) on the pulmonary artery (Fig. 1F ) and localized areas of ecchymotic haemorrhages in the epicardium. The liver also appeared congested and haemorrhagic and had a friable consistency. Foetus 4b demonstrated multifocal petechial haemorrhages of all lobes of the lung as well as bilateral pleural haemorrhages (Fig. 1G) . The remaining foetus (4c) similarly demonstrated bilateral pleural haemorrhages, petechiae and ecchymoses on all lobes of the lung, as well as localized areas of petechial and ecchymotic haemorrhages on the epicardium along the right coronary groove and auricles of the heart (Fig.   1H ). No pathology was observed in the negative control goats.
Completive enzyme linked immunosorbent assay
Goat number 4 demonstrated high levels of group-specific antibodies (>80% negativity) from the initial sampling (day -14) to euthanisation date (43 dpi) (Fig. 2) . Goats number 1-3 developed detectable group-specific antibodies (> 50% negativity) by 6 dpi that reached a plateau at 12 dpi (>80% negativity). None of the sera that were collected from the foetuses at necropsy tested positive for group-specific antibodies. The negative control animals similarly tested negative for group-specific antibodies against the virus.
Serum neutralization test
Neutralizing antibodies against BTV-8 were first detected in three of the inoculated goats at 6-7 dpi (goats 1-3) and reached a maximum titre between 20-28 dpi. The remaining goat (goat 4) demonstrated neutralizing antibodies against BTV-8 as early as 2 dpi that reached a maximum titre at 13 dpi. Neutralizing antibodies were not detected in any of the foetal sera that were harvested at necropsy nor in any of the sera that were collected from the negative control goats.
Real-time reverse-transcriptase PCR
Bluetongue virus RNA was first detected in the blood of one of the BTV-8 inoculated goats at day -14 (goat 4), at 1 dpi in goat 3, in one additional goat by 6 dpi (goat 1) and in the remaining goat (goat 2) by 7 dpi. Levels of RNA peaked at different time points for the different animals between 7-13 dpi (Ct = 28.42-34.26), after which there was a steady decline until the respective euthanisation dates. All four goats furthermore tested positive for BTV RNA in their blood at the time of euthanisation (13-43 dpi). A summary of the Ct values obtained from blood sampled from the adult goats (0-41 dpi) is presented in Table 1 . Bluetongue virus RNA was detected in several tissues harvested from the adult goats including heart, kidney, liver, lung, mammary tissue, spleen, submandibular lymph node, tongue, tonsils and uterus. Viral RNA was also detected in skin samples taken from the goats as early as 7 dpi, with skin samples from at least two goats still testing positive at 24 dpi ( Table 2) . Three of six foetuses (3a, 4a and 4c)
harvested from two goats (43 dpi) tested positive for viral RNA in either blood and/or tissue samples. Viral RNA was also detected in placental tissue from the two remaining goats (13-25 dpi) (Table 3) . Cycle threshold values for the majority of foetal and placental samples were high (>38 Ct), with the lowest value being detected in brain tissue harvested from foetus 1a at 43 dpi (day 105 of gestation, Ct =31.58). Blood and tissue samples collected from control animals tested negative for BTV viral RNA.
Conventional PCR and sequencing
Amplification products of the correct size were obtained from blood samples from each of the BTV-8 inoculated adult goats (samples taken between 4-13 dpi) as well as brain tissue from two foetuses (3a and 4c, 43 dpi). Sequencing of amplification products confirmed that all four adult goats and the two foetuses were infected with NET01/2007 (results not shown).
Sequencing furthermore indicated that the virus appears to have been relatively stable during its passage in tissue culture, with only one nucleotide change (silent) having occurred over the 499 bp region of the VP2 gene as compared to the published NET01/2007 reference sequence (Genbank accession number GQ506452).
Virus isolation
Replicating virus was detected in blood samples that were taken from the four BTV-8 inoculated adult goats between 7 -14 dpi, and that had previously demonstrated Ct values from 28 to 33 in the NS1 real-time RT-PCR. Infectious virus could not be demonstrated in any of the foetal blood samples or in blood samples from the negative controls.
Immunohistochemistry
Lymphatic tissues (lymph nodes, tonsils and spleen) demonstrated activation with the BTV-8 inoculated goats showing secondary follicle formation in the cortex and hyperplasia in the paracortex of the submandibular lymph nodes. Mild congestion in the lungs and sub-mandibular lymph nodes was also a prominent feature, along with mild focal areas of haemorrhage that were observed in several tissues (skin, pleural membranes, lung and sub-mandibular lymph nodes).
Only two foetuses demonstrated specific changes that included mild interstitial haemorrhage in the lungs and pleura (4b and 4c) as well as moderate sinusoidal congestion in the liver (4c). The presence of BTV VP7 antigen could not be demonstrated in any of the tissue sections examined.
Discussion
The date of inoculation of goats in the present study was chosen to coincide with the developmental stage of the ovine foetus when the most severe neurological malformations would be expected to occur following transplacental infection, but late enough to minimize the chances of abortion. Infection of ewes between days 50-60 of gestation for example has previously been demonstrated to lead to the birth of lambs with severe neurological malformations including hydranencephaly and retinal dysplasia (Young and Cordy, 1964; Richards and Cordy, 1967; Osburn et al., 1971) . In the present study the virus was passaged twice in cell culture to obtain a sufficient viral titre. The World Organization for Animal Health (OIE, 2004) recommends that viraemic blood from infected animals be used as inoculum instead of cell culture passaged virus for BTV challenge studies, as multiple passages of the virus in cell culture may change the virus' phenotypic properties (Flanagan and Johnson, 1995) . However, two recent studies have demonstrated that there are no appreciable differences in the progression of the disease in sheep or cattle, when these animals were given either of the two types of inocula (Eschbaumer et al., 2010; Martinelle et al., 2011) . Furthermore the low number of cell culture passages which were used to prepare the innoculum in this study is unlikely to have affected the phenotype of the (Spreull, 1905; Luedke and Anakwenze, 1972; Koumbati et al., 1999; Shimshony, 2004; Ting et al., 2005) . Acute disease has also been difficult to induce in goats experimentally infected with the European strain of BTV-8. In one study, of two Dutch dairy goats that were inoculated with BTV-8, only one demonstrated mild clinical signs (apathy, dysphagia, diarrhoea and lameness) whereas the other was sub-clinically infected .
The first rise in body temperature in the BTV-8 inoculated goats was observed between 1-3 dpi and was likely associated with the initial infection and replication. A second rise occurred between 6-10 dpi and likely reflected a more systemic reaction following disseminated infection of endothelial cells throughout the body. This second increase in body temperature coincided with an increase in BTV RNA levels in the blood of the animals between 7-13 dpi. A similar close relationship between the level of viral RNA in the blood and the occurrence of fever and clinical signs has previously been reported in experimentally infected sheep and cattle, although it has been pointed out that this correlation is not always clear cut (Darpel et al., 2007) .
Goat number 4 retrospectively tested positive for BTV group-specific antibodies and viral RNA prior to inoculation (day -14, 0 dpi), indicating a prior infection with BTV. The goats that were used in the trial were purchased from a known region of BTV endemicity and were tested for their serological status approximately three months (94 days) before challenge. Goat number 4 was probably sub-clinically infected with a field strain of BTV at this stage and had not yet sero-converted for group-specific antibodies against the virus. It is further also possible that the animal became infected when it was housed in the open stables during the synchronisation/AI step and could therefore have been infected while already pregnant. However if this is the case, the infection was sub-clinical as neither a febrile reaction nor clinical signs were noted in this animal during its stabling at the facility. The assay that was used for real-time RT-PCR in this study specifically targets the NS1 gene of BTV, and is thus unable to distinguish between infections caused by different serotypes. We were therefore unable to identify the infecting serotype from an analysis of the viral RNA in the positive blood sample that was collected from the animal prior to inoculation. However, the SNT results from serum collected at day -14 and 0 indicated that the animal had not yet sero-converted for BTV-8, indicating an infection with a different serotype. The prior infection of goat 4 with another serotype did not appear to have affected the animal's susceptibility to infection with BTV-8, as BTV RNA levels in the blood increased following BTV-8 inoculation, reflecting the active replication of the virus. The animal did however appear to demonstrate a more rapid serologic response than the other goats, with low titre neutralizing antibodies against BTV-8 being detectable as early as 2 dpi. Bluetongue virus serotypes are divided into distinct nucleotypes based on VP2 nucleotide and amino acid sequences . It has been demonstrated that viruses which belong to the same nucleotype demonstrate some degree of cross-neutralization in serological assays (Erasmus, 1990) . It is possible that the virus strain which previously infected goat number 4 and BTV-8 belong to the same nucleotype and that the earlier detection of BTV-8 specific antibodies in this animal reflects immunological cross-reactivity. Nevertheless, there appeared to be no difference in the clinical signs and/or pathological lesions in this animal, as compared to the other goats.
Together these results emphasize prior observations that infection with one serotype does not necessarily confer protection against infection with another (Howell, 1960; Howell et al., 1970; Jeggo and Wardley, 1985; Huismans et al., 1987; Eschbaumer et al., 2011) experimentally infected sheep for between 3-11 dpi, with labelling dramatically being reduced at 10 dpi (Mahrt and Osburn, 1986) . In the present study the animals were euthanised between 13-43 dpi, and by that time a reduction in viral antigen in the tissues could be expected. The use of polyclonal antibodies directed against VP7 may also not have been ideal for immuno-staining, as VP7 is expressed at a lower level than non-structural proteins such as NS1/NS2 (van Dijk and Huismans, 1988; Darpel et al., 2009b) .
The results of the serological, virological and post mortem examinations of the foetuses are summarized in Table 4 Immuno-tolerance and/or persistent/latent infections such as occur during the in utero exposure of cattle to bovine viral diarrhoea virus (BVDV) has not been demonstrated for BTV, despite prior reports of such occurrences (Luedke et al., 1977) . The latter result therefore probably reflects the immaturity of the foetal immune system at the time of infection, as production of antibodies in ruminants only starts around mid gestation (Osburn, 1994; Maclachlan et al., 2000) .
All six foetuses appeared normal on external examination. Gross lesions were more prominent than in the adult goats and appeared to have become more severe with increasing dpi.
Five of six foetuses (2a, 3a, and 4a-c) demonstrated lesions that may have been associated with transplacental infection, including haemorrhaging in several tissues, similar to what was observed in the adults. A focal area of haemorrhage was also found on the pulmonary artery in foetus 4a (Fig. 1F ). This is a common finding in BTV infected sheep and has been considered to be pathognomonic for BT (Erasmus, 1975) .
Despite evidence of infection of brain tissue in foetus 3a and 4c, neurological lesions could not be demonstrated. Notwithstanding the absence of malformation in the present study, the potential teratogenicity of BTV infection in goats cannot be excluded. Documented transplacental infection and associated defects vary widely in sheep and cattle and is therefore unpredictable (Osburn, 1994; Maclachlan et al., 2000) . Furthermore, in not all cases where animals were born either viraemic and/or PCR positive during the European outbreak of BTV-8
were nervous system lesions observed (De Clercq et al., 2008; Menzies et al., 2008; SantmanBerends et al., 2010; Saegerman et al., 2010) . It is possible that neurological lesions may have become apparent if the infected foetuses were allowed to have developed to term.
Interestingly Chaignat et al., (2009) antibodies. The animal also demonstrated signs of central nervous system dysfunction and died a few weeks after birth . From field observations it seems possible that TOV can cross the placenta in goats, although this has not been confirmed experimentally (Planzer et al., 2011) . Stillbirths and congenital abnormalities have furthermore also been reported in goats in Kuwait, possibly in associations with infections caused by the newly identified BTV-26 (Maan et al., 2011) .
The present study demonstrated for the first time that BTV-8 is able to cross the caprine placenta. The potential consequences for the foetus and overwintering of the virus are difficult to determine from the results of this study, due to the low number of pregnant animals that were included. Infected goat foetuses furthermore demonstrated low viral RNA levels in blood and tissue and would thus likely not have been born viraemic. The implication of these findings with regards to the epidemiology and overwintering of BTV-8 in Europe therefore remains unclear.
Future studies should include more pregnant animals and bring foetuses to term, in order to determine (a) whether transplacentally infected kids can be borne viraemic, (b) to evaluate the serological status of transplacentally infected kids at birth, and (c) to document possible BTV-8 associated teratogenecity. Adult goats of different breeds and gestational ages should also be used in order to explore host-specific variables with regards to transplacental infection with BTV-8 in this host species. Finally studies exploring the effects of co-infection with different BTV strains that can or cannot cross the placenta should also be initiated, in order to determine whether co-infection is a predisposing factor for transplacental infection of the virus.
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(Norway) and Torstedt's legacy (Norway Skin + (7, 13 dpi) + (7, 13, 24 dpi) + (7, 13, 24 dpi) + (7 dpi) Present a Goat number 4 tested positive for group specific antibodies against BTV prior to inoculation (day 0). (Fig. 1A ) Moderate hypaeremia and oedema of the cranial lobes of the lungs of goat number 2. (Fig. 1B) Congested submandibular lymph node in goat number 4. (Fig. 1C) Focal areas of endocardial petechiation in the ventricle of the heart of goat number 4. (Fig. 1D) Petechiation of all lobes of the lung in foetus 4a. (Fig. 1E ) Congested haemorrhagic liver in foetus 4a. (Fig. 1F ) Circular haemorrhagic patch on the pulmonary artery of foetus 4a. (Fig. 1G) Bilateral pleural haemorrhages observed in foetus 4c. (Fig. 1H ) Petechial an ecchymotic haemorrhages of the epicardium along the right coronary groove and auricle of the heart of foetus 4c.
Figure legends
Fig. 2.
Bluetongue virus group-specific antibody levels in adult goats measured at different intervals between -14 and 22 dpi. A cut-off value of 50% negativity was used to distinguish between positive and negative samples.
